Cas No. 289686-70-0, 2-(3,5-bis(trifluoroMethyl)phenyl)-2-Methyl propanoic acid

Fosnetupitant, a neurokinin-1 receptor antagonist, revolutionizes chemotherapy by effectively preventing and treating chemotherapy-induced nausea and vomiting (CINV). Our high-quality intermediates ensure a streamlined manufacturing process, providing a reliable supply of this game-changing medication. Partner with us to redefine supportive care in oncology, improving patient comfort and treatment adherence. Embrace Fosnetupitant and help shape the future of chemotherapy-induced symptom management.